← All candidates
21 insider filings on record.
24 filings on record.
CODXCo-Diagnostics, Inc.
NasdaqCM · Healthcare · $7.82M
$1.12
+2.70% · Sep 15
21 insider filings on record.
None of them an open-market buy in the last year.
Price · 1Y · dailyNo open-market activity in range
▸ hover a marker for the filing · drag to zoom · daily bars sharpen to 30-min on close ranges · 4 moves explained
Reverse-split 1×. When a company does a reverse split, the chart rewrites its old prices to look far bigger than they really were — so the high early prices here aren't what CODX ever actually traded at. The drop is real, but those huge old numbers aren't.
AI brief · from the filings on this pagePro
The filings, the score and the setup on this page, read for you in about ten seconds — what the insiders did, and what stands against it.
Market cap
$7.82M
Float
6.1M
88% public
Short % float
Pro
Price / profit
—
not yet profitable
Price / future profit
—
Price / sales
10.8
Institutional stakes
▸ a holder crossing 5% files Schedule 13D if they intend to act on the company, 13G if they certify they will not · /A amends an earlier filing
2 filingsnewest first
The record
newest first
DateTypeInsiderOf stakeShares @ priceValue
16 more transactions on Pro →Context
Wall St
$4.00 avg target
+257.1% vs today · 1 analyst
▸ relayed analyst opinion, which tends to run optimistic — not our forecast or advice
Earnings · EPS vs forecast
2 of 4 quarters beat
Q1 '26−$4.09 act−$0.34
Q4 '25−$4.44 act−$0.84
Q3 '25−$4.66 act+$1.04
Q2 '25−$7.01 act+$0.49
Coverage
Is Co-Diagnostics National Security’s Next Diagnostic Pick?MarketBeat · 05-28Co-Diagnostics (CODX) Q4 2025 Earnings TranscriptMotley Fool · 05-27CODX Stock Explodes Over 630% In Six Sessions – Retail Traders Bet The Rally Isn’t Over YetStocktwits · 05-26Co-Diagnostics Develops Ebola Assay Strategy Following WHO Emergency Alert (CODX)InvestorsHub · 05-19
The file stays open
24 filings on record.
The next one will be too.
▸ SEC EDGAR · FINRA · Nasdaq — public sources only · research, not advice